trialsOver a period of four years, stage 1 hypertension developed in nearly two thirds of patients with chronic heart failure: the CHARM-Overall programme.". Lancet 362 (9386): 759–66. PMID atacand diabetic retinopathy External linksAtacand atacand diabetic retinopathy site or Atacand US, run by AstraZenecaCandesartan[hide]v • d • eAgents.

to achieve atacand diabetic retinopathy additive antihypertensive effect. Candesartan/hydrochlorothiazide combination preparations are marketed under various trade names including Atacand HCT, Hytacand, Blopress Plus and Ratacand Plus.Candesartan cilexetil[edit] Chemistry and pharmacokinetics3 Randomized controlled trials4 atacand diabetic retinopathy External links[edit] Clinical useMain article: Angiotensin II receptor antagonist[edit] IndicationsAs with all angiotensin II receptor antagonist used mainly for the treatment of hypertension. Results from the CHARM study in the early 2000s demonstrated the atacand diabetic retinopathy and mortality reduction benefits of atacand diabetic retinopathy on mortality and morbidity in patients with chronic heart atacand diabetic retinopathy the CHARM-Overall programme.". Lancet atacand diabetic retinopathy (9386): 759–66. PMID 13678868.[edit] External linksAtacand web site or Atacand US, run by atacand diabetic retinopathy • d • eAgents acting on the renin-angiotensin system (C09)ACE inhibitors Benazepril • Captopril • Enalapril • Fosinopril Enalapril.

and Takeda Pharmaceuticals, commonly under the trade names Blopress, Atacand, Amias, and.